×
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
NASDAQ:SLP

Simulations Plus (SLP) Stock Forecast, Price & News

$48.75
+2.27 (+4.88%)
(As of 05/27/2022 04:00 PM ET)
Add
Compare
Today's Range
$46.89
$48.82
50-Day Range
$40.55
$51.76
52-Week Range
$35.18
$57.96
Volume
117,858 shs
Average Volume
115,252 shs
Market Capitalization
$985.09 million
P/E Ratio
88.64
Dividend Yield
0.52%
Beta
0.32
30 days | 90 days | 365 days | Advanced Chart
Receive SLP News and Ratings via Email

Sign-up to receive the latest news and ratings for Simulations Plus and its competitors with MarketBeat's FREE daily newsletter.

Simulations Plus logo

About Simulations Plus

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Current Symbol
NASDAQ:SLP
Employees
135
Year Founded
1996

Sales & Book Value

Annual Sales
$46.47 million
Cash Flow
$0.86 per share
Book Value
$8.23 per share

Profitability

Net Income
$9.78 million
Pretax Margin
28.20%

Debt

Price-To-Earnings

Miscellaneous

Free Float
15,543,000
Market Cap
$985.09 million
Optionable
Optionable

Company Calendar

Last Earnings
4/06/2022
Ex-Dividend for 5/2 Dividend
4/22/2022
Dividend Payable
5/02/2022
Today
5/27/2022
Next Earnings (Estimated)
7/11/2022
Fiscal Year End
8/31/2022

Social Links


MarketRank

Overall MarketRank

2.74 out of 5 stars

Computer And Technology Sector

46th out of 931 stocks

Computer Integrated Systems Design Industry

2nd out of 50 stocks

Analyst Opinion: 2.4Community Rank: 4.3Dividend Strength: 1.7Insider Behavior: 4.2Valuation: 1.3 5 -4 -3 -2 -1 -













Simulations Plus (NASDAQ:SLP) Frequently Asked Questions

Is Simulations Plus a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Simulations Plus stock.
View analyst ratings for Simulations Plus
or view top-rated stocks.

When is Simulations Plus' next earnings date?

Simulations Plus is scheduled to release its next quarterly earnings announcement on Monday, July 11th 2022.
View our earnings forecast for Simulations Plus
.

How were Simulations Plus' earnings last quarter?

Simulations Plus, Inc. (NASDAQ:SLP) announced its quarterly earnings results on Wednesday, April, 6th. The technology company reported $0.21 EPS for the quarter, topping analysts' consensus estimates of $0.14 by $0.07. The technology company earned $14.80 million during the quarter, compared to analysts' expectations of $15.03 million. Simulations Plus had a net margin of 23.13% and a trailing twelve-month return on equity of 6.86%. During the same quarter in the previous year, the company posted $0.15 EPS.
View Simulations Plus' earnings history
.

How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?

Simulations Plus declared a quarterly dividend on Wednesday, April 6th. Stockholders of record on Monday, April 25th will be given a dividend of $0.06 per share on Monday, May 2nd. This represents a $0.24 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date of this dividend is Friday, April 22nd.
View Simulations Plus' dividend history
.

Is Simulations Plus a good dividend stock?

Simulations Plus pays an annual dividend of $0.24 per share and currently has a dividend yield of 0.52%. The dividend payout ratio of Simulations Plus is 43.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Simulations Plus will have a dividend payout ratio of 33.80% next year. This indicates that Simulations Plus will be able to sustain or increase its dividend.
View Simulations Plus' dividend history.

What guidance has Simulations Plus issued on next quarter's earnings?

Simulations Plus updated its FY 2022 earnings guidance on Wednesday, April, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $51 million-$53 million, compared to the consensus revenue estimate of $52.86 million.

What price target have analysts set for SLP?

4 equities research analysts have issued 1 year price targets for Simulations Plus' stock. Their forecasts range from $53.00 to $75.00. On average, they anticipate Simulations Plus' share price to reach $60.67 in the next year. This suggests a possible upside of 24.4% from the stock's current price.
View analysts' price targets for Simulations Plus
or view top-rated stocks among Wall Street analysts.

Who are Simulations Plus' key executives?
Simulations Plus' management team includes the following people:
  • Mr. Walter S. Woltosz M.A.S., M.S., Co-Founder & Chairman (Age 77, Pay $91.04k)
  • Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 62, Pay $544.23k)
  • Mr. William Frederick, CFO & Sec. (Age 58, Pay $371.7k)
  • Mr. John Anthony DiBella M.S., Pres of Simulations Plus Division (Age 42, Pay $312.15k)
  • Dr. Brett A. Howell Ph.D., Pres of DILIsym Services, Inc (Age 38, Pay $249.35k)
  • Ms. Jill Fiedler-Kelly M.S., MS, Pres of Cognigen Division (Age 52, Pay $251.89k)
  • Ms. Viera Lukacova Ph.D., Chief Scientific Officer
  • Ms. Arlene Padron, Corp. Director of Marketing
  • Ms. Lindsay Luke, Exec. Director of HR
  • Dr. Scott Q. Siler, Chief Scientific Officer of DILIsym Services, Inc
What other stocks do shareholders of Simulations Plus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Simulations Plus investors own include Advanced Micro Devices (AMD), Cisco Systems (CSCO), Gilead Sciences (GILD), QUALCOMM (QCOM), NVIDIA (NVDA), Verizon Communications (VZ), CVS Health (CVS), Enterprise Products Partners (EPD), AbbVie (ABBV) and Pfizer (PFE).

What is Simulations Plus' stock symbol?

Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."

Who are Simulations Plus' major shareholders?

Simulations Plus' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.14%), Conestoga Capital Advisors LLC (11.02%), Neuberger Berman Group LLC (8.10%), Vanguard Group Inc. (5.39%), State Street Corp (3.51%) and Invesco Ltd. (2.22%). Company insiders that own Simulations Plus stock include David L Ralph, John Anthony Dibella II, John Kenneth Paglia, Lisa Lavange, Shawn Oconnor, Walter S Woltosz and Walter S Woltosz.
View institutional ownership trends for Simulations Plus
.

Which major investors are selling Simulations Plus stock?

SLP stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Russell Investments Group Ltd., Wasatch Advisors Inc., Aviva PLC, BNP Paribas Arbitrage SA, Principal Financial Group Inc., Stanley Laman Group Ltd., and InTrack Investment Management Inc. Company insiders that have sold Simulations Plus company stock in the last year include John Kenneth Paglia, and Walter S Woltosz.
View insider buying and selling activity for Simulations Plus
or view top insider-selling stocks.

Which major investors are buying Simulations Plus stock?

SLP stock was purchased by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Rice Hall James & Associates LLC, Kopion Asset Management LLC, JPMorgan Chase & Co., State Street Corp, Rice Hall James & Associates LLC, BlackRock Inc., and Invesco Ltd..
View insider buying and selling activity for Simulations Plus
or or view top insider-buying stocks.

How do I buy shares of Simulations Plus?

Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Simulations Plus' stock price today?

One share of SLP stock can currently be purchased for approximately $48.75.

How much money does Simulations Plus make?

Simulations Plus has a market capitalization of $985.09 million and generates $46.47 million in revenue each year. The technology company earns $9.78 million in net income (profit) each year or $0.55 on an earnings per share basis.

How many employees does Simulations Plus have?

Simulations Plus employs 135 workers across the globe.

When was Simulations Plus founded?

Simulations Plus was founded in 1996.

What is Simulations Plus' official website?

The official website for Simulations Plus is www.simulations-plus.com.

How can I contact Simulations Plus?

Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at (661) 723-7723, via email at i[email protected], or via fax at 661-723-5524.

This page was last updated on 5/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.